Erlin-2 is associated with active γ-secretase in brain and affects amyloid β-peptide production

Yasuhiro Teranishi1, Ji-Yeun Hur, Gucci Jijuan Gu

  • 1Karolinska Institutet Dainippon Sumitomo Pharma Alzheimer Center, KI-Alzheimer Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Stockholm SE-141 86, Sweden.

Insights

Researchers discovered erlin-2, a novel protein associated with gamma-secretase, which influences amyloid beta-peptide (Aβ) production. This finding is crucial for developing targeted Alzheimer disease therapies by selectively inhibiting Aβ generation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • The gamma-secretase complex cleaves amyloid precursor protein (APP) to produce neurotoxic amyloid beta-peptide (Aβ), a key factor in Alzheimer disease pathogenesis.
  • Selective inhibition of APP processing by gamma-secretase is a therapeutic challenge due to its numerous other substrates.
  • Gamma-secretase associated proteins (GSAPs) are implicated in substrate selection and processing.

Purpose of the Study:

  • To identify novel GSAPs involved in gamma-secretase substrate processing.
  • To investigate the role of identified GSAPs in Aβ production and Alzheimer disease.
  • To explore potential therapeutic strategies targeting specific gamma-secretase interactions.

Main Methods:

  • Affinity purification of gamma-secretase and associated proteins using a specific inhibitor.
  • Tandem mass spectrometry for protein identification.
  • Co-immunoprecipitation and proximity ligation assays to confirm protein interactions.
  • siRNA experiments to assess the functional impact of erlin-2 on Aβ and Notch processing.

Main Results:

  • A novel brain GSAP, erlin-2, was identified and found to associate with gamma-secretase.
  • Erlin-2 predominantly resides in detergent-resistant membranes (DRMs) and its association with gamma-secretase is higher in DRMs.
  • Reduced erlin-2 levels led to decreased Aβ production with minimal impact on Notch processing.

Conclusions:

  • Erlin-2 is a novel brain-specific GSAP that interacts with gamma-secretase within DRMs.
  • Erlin-2 plays a role in modulating Aβ production, suggesting it as a potential therapeutic target for Alzheimer disease.
  • The findings highlight the importance of GSAPs in understanding and targeting gamma-secretase activity.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...